Published in Eur Urol on January 18, 2006
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol (2012) 1.65
Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J (2009) 1.13
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review. Int J Clin Exp Pathol (2012) 0.99
Plasmacytoid urothelial carcinoma of the bladder: a case report. Cases J (2009) 0.93
Two cases of plasmacytoid variant of urothelial carcinoma of urinary bladder: systemic chemotherapy might be of benefit. Int J Clin Oncol (2011) 0.92
Plasmacytoid urothelial carcinoma of the bladder metastatic to the stomach: a case report. Case Rep Urol (2012) 0.86
A rare case of plasmacytoid urothelial carcinoma of bladder: Diagnostic dilemmas and clinical implications. Indian J Urol (2011) 0.84
Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder. Hum Pathol (2012) 0.80
HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder. Dis Markers (2016) 0.78
[Not Available]. Can Urol Assoc J (2014) 0.75
Isolated cardiac metastasis from plasmacytoid urothelial carcinoma of the bladder. Exp Hematol Oncol (2012) 0.75
Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation. Can Urol Assoc J (2017) 0.75
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol (2016) 0.75
[Plasmacytoid carcinoma. Five case reports of a rare variant of urothelial carcinoma]. Pathologe (2008) 0.75
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2002) 2.51
Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. BJU Int (2012) 2.47
Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. Eur Urol (2008) 2.43
Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol (2011) 2.18
Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma. Can Urol Assoc J (2009) 2.00
Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol (2002) 1.88
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer (2012) 1.70
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology (2005) 1.63
The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology (2012) 1.57
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. Leuk Lymphoma (2009) 1.55
The prognostic significance of capsular incision into tumor during radical prostatectomy. Eur Urol (2010) 1.53
CyberKnife for inoperable renal tumors: Canadian pioneering experience. Can J Urol (2013) 1.47
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol (2005) 1.45
Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int (2010) 1.31
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol (2002) 1.28
Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma. J Oncol Pract (2013) 1.21
Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. Can Urol Assoc J (2010) 1.19
The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma (2006) 1.17
Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene (2003) 1.11
Movember update: The Canadian perspective. Can Urol Assoc J (2012) 1.08
Surveillance strategies after definitive therapy of invasive bladder cancer. Can Urol Assoc J (2009) 1.08
Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience. Can Urol Assoc J (2011) 1.07
Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med (2009) 1.06
Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Int J Surg Pathol (2005) 1.06
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J Urol (2004) 1.06
A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol (2007) 1.03
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Can Urol Assoc J (2013) 1.02
Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol (2005) 1.02
Renal and functional outcomes following cystectomy and neobladder reconstruction. Can Urol Assoc J (2010) 0.99
Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. BJU Int (2012) 0.98
Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury. Asian J Androl (2008) 0.96
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol (2002) 0.96
Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res (2008) 0.95
Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Int J Radiat Oncol Biol Phys (2012) 0.95
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. Urology (2003) 0.94
Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer. BMC Cancer (2013) 0.93
Hybrid chromophobe renal cell neoplasm. Pathol Res Pract (2005) 0.93
Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. Cancer Genet Cytogenet (2002) 0.92
Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implants. Radiother Oncol (2006) 0.92
Prostate cancer as a model system for genetic diversity in tumors. Adv Cancer Res (2011) 0.91
Predictive value of prostatic adenocarcinoma after a negative prostate biopsy. BJU Int (2006) 0.89
Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis. BJU Int (2013) 0.88
The association between tumour density and prostate cancer recurrence following radical prostatectomy. Can Urol Assoc J (2011) 0.88
The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neurooncol (2004) 0.88
Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system. Can Urol Assoc J (2013) 0.87
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. Prostate (2003) 0.87
Postoperative radiotherapy in prostate cancer: the case of the missing target. Int J Radiat Oncol Biol Phys (2012) 0.86
A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process? Saudi Med J (2005) 0.86
Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol (2007) 0.86
Ovarian granulocytic sarcoma. Leuk Lymphoma (2004) 0.85
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada. Can Urol Assoc J (2012) 0.84
Microarray CGH. Methods Mol Biol (2002) 0.84
What next? Managing lymph nodes in men with penile cancer. Can Urol Assoc J (2008) 0.84
Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma. Appl Immunohistochem Mol Morphol (2004) 0.84
The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev (2012) 0.83
Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Pathology (2002) 0.83
Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity. Int J Radiat Oncol Biol Phys (2004) 0.83
Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort. Can Urol Assoc J (2012) 0.82
High-risk clinical stage I NSGCT: the case for RPLND. World J Urol (2009) 0.82
Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas. Leuk Res (2007) 0.82
Effects of caffeine on neuronal apoptosis in neonatal hypoxic-ischemic brain injury. J Matern Fetal Neonatal Med (2014) 0.82
Application of ice cold irrigation during vascular pedicle control of robot-assisted radical prostatectomy: EnSeal instrument cooling to reduce collateral thermal tissue damage. J Endourol (2010) 0.81
VEGF-C expression in breast cancer: clinical importance. Adv Ther (2006) 0.81
Therapeutic plasma exchange in treatment of neuroimmunologic disorders: review of 92 cases. Transfus Apher Sci (2013) 0.81
Array comparative genomic hybridization in osteosarcoma. Methods Mol Biol (2013) 0.81
Immunoexpression of androgen receptor in the nontumorous pituitary and in adenomas. Endocr Pathol (2008) 0.80
Nonsynergistic effects of trimetazidine and selenium combination therapy on renal ischemic-reperfusion injury in rats. Adv Ther (2004) 0.80
A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol Res Pract (2003) 0.80
Analysis of PTEN, VEGF, HER2 and P53 status in determining colorectal cancer benefit from bevacizumab therapy. Asian Pac J Cancer Prev (2012) 0.80
Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol (2006) 0.80
Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database. Urol Oncol (2011) 0.80
Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? World J Urol (2012) 0.78
Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin's lymphoma. Am J Hematol (2004) 0.78
Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists. PLoS One (2013) 0.78
"Honey" can prevent epidural fibrosis development after laminectomy: an experimental study. Turk Neurosurg (2014) 0.78
Cyclooxygenase-2 expression in non-Hodgkin's lymphomas. Leuk Lymphoma (2007) 0.78
Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast Cancer. Cancers (Basel) (2011) 0.78
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol (2013) 0.78
Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer. World J Urol (2013) 0.77
An unusual cause of hematospermia: Primary adenocarcinoma of the seminal vesicle. Can Urol Assoc J (2012) 0.77
Effects of Long-term Administration of the Antiaging Hormone Dehydroepiandrosterone Sulfate on Rat Prostates and Testes as Androgen-Dependent Organs. Korean J Urol (2013) 0.77
Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts. Arthritis Res Ther (2014) 0.77
Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma. Can Urol Assoc J (2013) 0.77
Different glomerulopathies accompanying non-small-cell lung cancer. Mt Sinai J Med (2005) 0.77
Identification of isolated and early prostatic adenocarcinoma in radical prostatectomy specimens with correlation to biopsy cores: clinical and pathogenetic significance. Pathol Res Pract (2002) 0.76
Left atrial vein pacing: a technique of biatrial pacing for the prevention of atrial fibrillation. Pacing Clin Electrophysiol (2004) 0.76
Renal sarcoma and associated malignant pulmonary embolism: a report of 2 cases. Can Urol Assoc J (2007) 0.75
Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience. Can Urol Assoc J (2012) 0.75